KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Capital Expenditures (2016 - 2025)

Charles River Laboratories International has reported Capital Expenditures over the past 17 years, most recently at $89.0 million for Q4 2025.

  • Quarterly results put Capital Expenditures at $89.0 million for Q4 2025, up 17.63% from a year ago — trailing twelve months through Dec 2025 was $219.2 million (down 5.93% YoY), and the annual figure for FY2025 was $219.2 million, down 5.93%.
  • Capital Expenditures for Q4 2025 was $89.0 million at Charles River Laboratories International, up from $35.6 million in the prior quarter.
  • Over the last five years, Capital Expenditures for CRL hit a ceiling of $106.9 million in Q2 2023 and a floor of $28.0 million in Q1 2021.
  • Median Capital Expenditures over the past 5 years was $69.9 million (2022), compared with a mean of $66.2 million.
  • Biggest five-year swings in Capital Expenditures: soared 187.06% in 2022 and later crashed 41.4% in 2024.
  • Charles River Laboratories International's Capital Expenditures stood at $98.8 million in 2021, then fell by 9.87% to $89.0 million in 2022, then decreased by 12.02% to $78.3 million in 2023, then decreased by 3.46% to $75.6 million in 2024, then increased by 17.63% to $89.0 million in 2025.
  • The last three reported values for Capital Expenditures were $89.0 million (Q4 2025), $35.6 million (Q3 2025), and $35.3 million (Q2 2025) per Business Quant data.